Neoplasms: all 9,616 studies
Page 81 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- NHS-IL12 for Solid TumorsCompletedNCT01417546Phase 1
- A Phase I Study of Henatinib in Patients With Advanced Solid MalignanciesTerminatedNCT01416623Phase 1
- Cardiovascular Function in Adult Survivors of Childhood MalignanciesCompletedNCT01415999
- Dose Escalation Study of NKP-1339 to Treat Advanced Solid TumorsCompletedNCT01415297Phase 1
- Screening for Vulnerability in the Elderly Supported at the Oscar Lambret CentreCompletedNCT01415258
- An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid TumorsCompletedNCT01413893Phase 1
- Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary StentTerminatedNCT01413386Not applicable
- A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4CompletedNCT01409135Phase 1
- Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid TumorsTerminatedNCT01407562Phase 1
- Study of PWT33597 Mesylate in Subjects With Advanced MalignanciesCompletedNCT01407380Phase 1
- An Extension Study of ABT-806 in Subjects With Advanced Solid TumorsCompletedNCT01406119Phase 1
- Longitudinal Evaluation Study of Vaginal Stenosis With and Without Pelvic Radiation TherapyCompletedNCT01404728
- Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid TumorsCompletedNCT01401933Phase 1
- Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid TumorsCompletedNCT01401868Phase 1
- Study of an Investigational Drug, ASP3026, in Patients With Solid TumorsCompletedNCT01401504Phase 1
- Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.CompletedNCT01398306
- ICG Fluorescence Technique for the Detection of Sentinel Lymph NodesStatus unknownNCT01395706Phase 2
- Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Brain MetastasesCompletedNCT01395407Phase 1
- Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsCompletedNCT01395056
- The First-in-human Phase I Trial of PU-H71 in Patients With Advanced MalignanciesCompletedNCT01393509Phase 1
- Safety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid TumorsCompletedNCT01392976Phase 1
- Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid TumorsCompletedNCT01392924Phase 1
- Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid TumorsCompletedNCT01391533Phase 1
- A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid NeoplasmsCompletedNCT01387763Phase 3
- A Study of BYL719 in Adult Patients With Advanced Solid MalignanciesCompletedNCT01387321Phase 1
- Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid TumorsCompletedNCT01386866Phase 1
- Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic AstrocytomaSuspendedNCT01386710Phase 1/2
- DIBH Proton PlanningCompletedNCT01386697
- Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal CancerCompletedNCT01386346Phase 1
- Endoscopic Multispectral Imaging for the Early Detection of Barrett's NeoplasiaCompletedNCT01384864Early Phase 1
- Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio ImmunotherapyCompletedNCT01384253Phase 1
- Confocal Endomicroscopy Detection of Gastric Preneoplasia and NeoplasiaCompletedNCT01384201
- Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine TumorsStatus unknownNCT01381822Phase 1
- PDM08 Clinical Trial in Advanced Solid TumorsCompletedNCT01380249Phase 1
- Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid TumorsCompletedNCT01379287Phase 1
- Endoscopic Submucosal Dissection for Gastrointestinal NeoplasmsStatus unknownNCT01378507Not applicable
- Vaccine Therapy in Treating Patients With Metastatic Solid TumorsCompletedNCT01376505Phase 1
- A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT01375842Phase 1
- Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly PaclitaxelCompletedNCT01374620Phase 1
- Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction StudyCompletedNCT01372917
- Molecular Imaging of Epidermal Growth Factor Receptor in Colorectal Neoplasia Using Confocal Laser EndomicroscopyCompletedNCT01372189
- Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical CancerStatus unknownNCT01371695
- GSK1120212 Food-effect StudyCompletedNCT01371487Phase 1
- Collaborative Seamless Care in Oncology : Measure and Reinforce Safety and Adherence to Oral Cancer TreatmentCompletedNCT01370980
- Molecular Profiling of Metastatic Cancer in Pleural Effusion and AscitesStatus unknownNCT01369992
- Optimal Management of Malignant DysphagiaTerminatedNCT01366833Not applicable
- Natural History of HPV From Infection to Neoplasia in Adolescents and Young WomenCompletedNCT01366742
- Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor PatientsCompletedNCT01363232Phase 1
- Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid TumorsCompletedNCT01363024Phase 1
- National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer PatientsCompletedNCT01362933
- Structured Multidisciplinary Intervention or Standard Medical Care in Improving Quality of Life in Patients Receiving Active Cancer TreatmentCompletedNCT01360814
- Tissue Characterisation by Endoscopic GI-elastographyCompletedNCT01360411
- A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or LymphomaCompletedNCT01359696Phase 1
- A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid TumorsCompletedNCT01358227Phase 1
- Emergency Department-Based Palliative Care for Advanced Cancer PatientsCompletedNCT01358110Not applicable
- Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-upActive, not recruitingNCT01357772Phase 3
- Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT01357330Phase 1
- Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent VaccineCompletedNCT01356823Phase 2
- Prospective Study Comparing Methods of Obtainment of Specimen After EUS-FNA in Patients With Peri-pancreatic MassCompletedNCT01354795Not applicable
- Open Label Phase 1 Study in Japan for Patient With Advanced Solid MalignanciesCompletedNCT01353781Phase 1
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.CompletedNCT01353625Phase 1
- Robotic Compared to Fixed Gantry Radiosurgery for Brain MetastasesStatus unknownNCT01353573Phase 3
- MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E MutationsCompletedNCT01352273Phase 1
- BIBF 1120 and RAD001 in Solid Tumors - Phase ICompletedNCT01349296Phase 1
- E-health Intervention for Cancer Survivors 2.0WithdrawnNCT01348997Phase 1
- A Dose Escalation Study of OMP-18R5 in Subjects With Solid TumorsCompletedNCT01345201Phase 1
- Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)CompletedNCT01344707Phase 1
- Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid TumorsCompletedNCT01343498Phase 1
- Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid CancerCompletedNCT01341886Not applicable
- Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor RemovalTerminatedNCT01341496Phase 1
- Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese SubjectsCompletedNCT01340040Phase 1
- Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaCompletedNCT01339975
- Study of Pazopanib and Vorinostat in Patients With Advanced MalignanciesCompletedNCT01339871Phase 1
- Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor PatientsCompletedNCT01337765Phase 1
- Haploidentical Stem Cell Transplantation and IL-15 NK Cell Infusion for Paediatric Refractory Solid TumoursTerminatedNCT01337544Phase 1/2
- Safety and Maximum Tolerated Dose (MTD) Study of INNO-206 in Subjects With Advanced Solid TumorsCompletedNCT01337505Phase 1
- Study of Tesetaxel in Japanese Patients With Solid TumorsStatus unknownNCT01337310Phase 1
- Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting BeadsTerminatedNCT01336985Phase 1
- CD56+CD3- NK Cells Following Allogeneic Stem Cell TransplantationWithdrawnNCT01336478Phase 1
- Clinical Study to Evaluate Safety and Maximum Tolerated Dose of BAY1000394 Given in a 4 Week on / 2 Week Off Schedule in Subjects With Advanced MalignanciesCompletedNCT01335256Phase 1
- Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck CancerTerminatedNCT01333852Phase 2
- Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal CarcinomaCompletedNCT01333709Phase 2
- Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain MetastasisCompletedNCT01332929Phase 1
- Aflac ST0901 CHOANOME - Sirolimus in Solid TumorsCompletedNCT01331135Phase 1
- A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsCompletedNCT01325558Phase 1
- Study of INC280 in Patients With c-MET Dependent Advanced Solid TumorsCompletedNCT01324479Phase 1
- Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid TumorsCompletedNCT01324258Phase 1
- NG-Nitro-L-Arginine in Treating Patients With Advanced Solid TumorsTerminatedNCT01324115Phase 1
- First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid TumorsCompletedNCT01323933Phase 1
- Economisation of Whipple Resection Using an Ultrasonic Dissection DeviceCompletedNCT01321450
- The 'SILVERMAN1' Trial Single Incision Laparoscopic Versus Existing Resection (Minimal Access) for NeoplasiaStatus unknownNCT01319890
- A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological MalignanciesCompletedNCT01317927Phase 1
- PET-CT in Diagnosis of Pancreatic Cystic NeoplasmsCompletedNCT01317836
- Glivec in Prostate Cancer Patients With Rising PSA Following Radical ProstectomyCompletedNCT01316458Phase 2
- A Study of Tesetaxel Plus Capecitabine in Patients With Solid TumorsStatus unknownNCT01315431Phase 1
- GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid TumorsCompletedNCT01313598Phase 1
- Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or MediastinumTerminatedNCT01313429Phase 1
- Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or CancerWithdrawnNCT01313104Not applicable
- Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid TumorsCompletedNCT01313065Phase 1
- A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell NeoplasmsCompletedNCT01309789Phase 1